Shree Ganesh Bio-Tech (India) Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Shree Ganesh Bio-Tech (India) Ltd. on BSE

Load latest

Shree Ganesh Bio-Tech (India) Ltd.

02 Oct 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Statement Of Investor Complaints For The Quarter Ended September 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- VARUN PRAVINCHANDRA AGHARADesignation :- Chief Financial Officer

Shree Ganesh Bio-Tech (India) Ltd.

29 Sep 2020, 05:07PM

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by NSE vide letter no. NSE/CML/2019/11 dated 2nd April 2019 and BSE vide circular no. LIST/COMP/01/2019-20 regarding trading restriction period and Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed from Thursday, 1st October 2020 till 48 hours after announcement / declaration of Unaudited Financial Results for the Quarter and half year ended on 30th September, 2020. The date of Board Meeting for declaration of the Unaudited Financial Results of the company for the quarter ended and half year ended on 30th September, 2020 will be informed in due course.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

29 Sep 2020, 03:45PM

SAST

Shree Ganesh Biotech (India) Ltd - 539470 - Closure of Trading Window

BSE India

Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended and clarification given by NSE vide letter no. NSE/CML/2019/11 dated 2nd April 2019 and BSE vide circular no. LIST/COMP/01/2019-20 regarding trading restriction period and Company''s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in the securities of the Company will remain closed from Thursday, 1st October 2020 till 48 hours after announcement / declaration of Unaudited Financial Results for the first quarter ended on 30th September, 2020. The date of Board Meeting for declaration of the Unaudited Financial Results of the company for the quarter ended and half year ended on 30th September, 2020 will be informed in due course.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

26 Sep 2020

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Shree Ganesh Biotech (India) Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Shree Ganesh Bio-Tech (India) Ltd.

26 Sep 2020

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the voting results of the business transacted at the Annual General Meeting of the Company held on Saturday, the 26th September 2020 at 11:00 A.M. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') in the prescribed format. Kindly take note of the above. Thanking you.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

26 Sep 2020

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

26 Sep 2020

AGM

Shree Ganesh Biotech (India) Ltd - 539470 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

In terms of Regulation 30 read with Part A of Schedule lll of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), we hereby inform you that the following businesses were transacted at the 10th Annual General Meeting of the Company held on Saturday, 26th September 2020 at 11:00 A.M. through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM') at Registered office of the company: 1. Ordinary Resolution for adoption of the audited financial statements of the Company for the Financial Year ended 31st March 2020 and Reports of the Directors and Auditors thereon. 2. Ordinary Resolution for Appointment Statutory Auditors and fix their remuneration. 3. Special Resolution for Appointment of Mr. AMAN PATEL as the Whole Time Director of the company for the period of 3 years. The above and other businesses were transacted and passed by the shareholders at Annual General Meeting. Kindly take note of the above. Thanking you,

pdf

Shree Ganesh Bio-Tech (India) Ltd.

08 Sep 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 31st March 2020, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records.

pdf

Shree Ganesh Bio-Tech (India) Ltd.

08 Sep 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation …

BSE India

pdf

Shree Ganesh Bio-Tech (India) Ltd.

08 Sep 2020

Company Update

Shree Ganesh Biotech (India) Ltd - 539470 - Nil Statement On Deviation Or Variation Of Funds …

BSE India

As per the SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, issued by the SEBI titled "Format on Statement of Deviation or Variation for proceeds of public issue, rights issue, preferential issue, Qualified Institutions Placement (QIP) etc." and pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith is a Nil statement issued by the Company on the captioned subject. This is for the information of the exchange and the members.

pdf

Is Shree Ganesh Bio-Tech (India) Ltd. worth buying?

272 Votes:

Buy 73.53%

Sell 8.82%

Hold 17.65%